Cannabis stocks saw a short-lived rally Tuesday following reports that the DEA will move to reschedule marijuana from a Schedule I to a Schedule III substance. The DEA’s proposal would recognize the medical uses of cannabis and acknowledge it has less potential for abuse than Schedule I substances.
Recent Comments